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Abstract
Since nasopharyngeal carriage of pneumococcus precedes invasive pneumococcal disease, characteristics of carriage
isolates could be incorrectly assumed to reflect those of invasive isolates. While most pneumococci express a capsular
polysaccharide, nontypeable pneumococci are sometimes isolated. Carriage nontypeables tend to encode novel surface
proteins in place of a capsular polysaccharide synthetic locus, the cps locus. In contrast, capsular polysaccharide is believed
to be indispensable for invasive pneumococcal disease, and nontypeables from population-based invasive pneumococcal
disease surveillance have not been extensively characterized. We received 14,328 invasive pneumococcal isolates through
the Active Bacterial Core surveillance program during 2006–2009. Isolates that were nontypeable by Quellung serotyping
were characterized by PCR serotyping, sequence analyses of the cps locus, and multilocus sequence typing. Eighty-eight
isolates were Quellung-nontypeable (0.61%). Of these, 79 (89.8%) contained cps loci. Twenty-two nontypeables exhibited
serotype 8 cps loci with defects, primarily within wchA. Six of the remaining nine isolates contained previously-described aliB
homologs in place of cps loci. Multilocus sequence typing revealed that most nontypeables that lacked capsular
biosynthetic genes were related to established non-encapsulated lineages. Thus, invasive pneumococcal disease caused by
nontypeable pneumococcus remains rare in the United States, and while carriage nontypeables lacking cps loci are
frequently isolated, such nontypeable are extremely rare in invasive pneumococcal disease. Most invasive nontypeable
pneumococci possess defective cps locus genes, with an over-representation of defective serotype 8 cps variants.
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Introduction
Pneumococcal infections remain a leading cause of morbidity
and mortality worldwide [1]. Clinically-used pneumococcal
vaccines target the capsular polysaccharide (CPS), which is
considered a requirement for virulence and exceeds 94 known
serotypes [2–6]. Since the implementation of widespread vacci-
nation, serotypes represented in vaccines are isolated less
frequently in both nasopharyngeal carriage and invasive pneumo-
coccal disease (IPD), while certain non-vaccine serotypes are
isolated more frequently [7–9]. Monitoring the serotype distribu-
tion of pneumococcal infections is thus vital to the prospective
control and prevention of pneumococcal disease.
While the majority of IPD isolates are encapsulated organisms
that are serotypeable with typing antisera, nontypeable isolates
(NTs) are sometimes recovered [10–12]. NTs may represent
pneumococci that exhibit novel CPS types, have damaged or
substituted capsule synthetic genes, or produce CPS below
detection. NTs have been broadly categorized according to the
contents of the CPS biosynthetic locus (cps), the site of genes for
CPS synthesis between dexB and aliA in all known serotypes but
one [2,13]. Group I NTs retain at least partial cps loci; Group II
NTs lack cps loci but in their place contain genes encoding novel
proteins [10,14]. Park, et al, further divided Group II NTs into
clades [14]. Null Capsule Clade (NCC) 1 isolates contain pspK,
which encodes a novel surface protein [14,15]. NCC2 and NCC3
isolates contain aliB homologs, aliC (NCC2 only) and aliD, which
encode putative lipoproteins of unknown function [10,12,14].
NCC isolates have been frequently described among carriage
NTs [10,12,14]. Because nasopharyngeal carriage of pneumococ-
cus is a prerequisite for IPD, characteristics of carriage isolates
have been used to infer characteristics of IPD isolates; however,
the nature of IPD NTs is unclear given the protective role of CPS,
and the prevalence of IPD NTs is unknown. Rates as high as 3–
4% of IPD strains have been reported to be NT based on studies of
a limited number of isolates (,30) from Native American
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populations [11,16,17]. However, over 2006 and 2007, NT
isolates accounted for only 0.86% of IPD cases reported to the
Centers for Disease Control and Prevention through the Active
Bacterial Core surveillance program [18]. The majority of
characterized IPD NTs have been Group I NT [11,12], and
Scott and colleagues hypothesized that in Group I NTs with intact
genetic elements (as determined by microarray), CPS is expressed
below what Quellung serotyping would detect [11]. The power of
studies on IPD NTs has been limited by the relative rarity of such
isolates and lack of detailed sequence analyses of cps loci.
From 2006 to 2009, 14,328 pneumococcal IPD isolates were
recovered from 10-state population surveillance by Centers for
Disease Control and Prevention (CDC) Active Bacterial Core
surveillance (ABCs) and subjected to Quellung-based serotyping.
Here we describe the characterization of 88 NT strains, the largest
collection of IPD NTs examined to date. While the majority were
Group I NT, nine Group II NT were identified and analyzed by
multi-locus sequence typing (MLST) to determine their relatedness
to other NT isolates. In addition, we characterized the molecular
defects of the overrepresented PCR-serotype 8 (PCR-8) isolates
and determined that all have mutations likely to eliminate CPS
production.
Methods
Strains and Conditions
Strains were obtained by the CDC ABCs program and cultured
in Todd Hewitt broth (BD Biosciences) supplemented with 0.5%
yeast extract or on tryptic soy agar plates supplemented with 5%
sheep’s blood (BAP).
Quellung Serotyping
Serotyping was performed as previously described [19] by the
(Streptococcus Laboratory or by the Minnesota Department of Public
Health.
Genetic Analyses
Primers used in this study are presented in Table S1. The CDC
PCR-serotyping assays have been described previously [19,20],
updates provided at www.cdc.gov/ncidod/biotech/strep/pcr.htm.
One isolate was typed using a separate multiplexed PCR assay,
described previously [21]. cpsA was detected using multiplex PCR
assay [21] and/or in conventional PCR using primer sets cpsA-f/
cpsA-r, 5202/3202, or 5694/3694.
Chromosomal DNA from PCR-8 strains was initially assessed
for gross defects in wchA using primer set 5114/3695, and products
were sequenced with primer 5114. For extreme 39 coverage of
wchA, amplicons were generated using primer set 5830/3828 and
sequenced with primer 5832. For whole cps locus sequencing, locus
fragments were generated using primer sets 5825/3826, 5830/
3828, 5835/3830, and 5840/3832 and sequenced using primers
internal to each fragment. PCR using various combinations of
primers and agarose gel electrophoresis were used to identify the
region of gross defect in isolate 6265-07 prior to sequencing.
Isolate 7236-07 cps locus was initially sequenced with primer set
5419/3419 and in subsequent steps by primers generated to
sequences from the previous reaction.
Detection of NCC genes [14], PCR for dexB/aliA [10,14], and
MLST [22,23] were performed as previously described.
DNA Sequencing
PCR products were sequenced by the Heflin Center Genomics
Core Lab, University of Alabama at Birmingham.
Statistical Analyses
Statistical analyses were performed in Microsoft Excel. Testing
for overrepresentation among PCR-serotypeable NTs was per-
formed by chi-squared analysis using expected values generated
from prevalence data over the study period using an assumed
sample size of 79 (i.e., the number of PCR-serotypeable isolates).
Comparisons for PCR-serotypeable isolates relative to Quel-
lung-typeable counterparts were performed by dividing the raw
numbers of each group for a given serotype and confined to PCR-
serotypes with two or more isolates. Serotype 8 was a statistical
outlier as determined by Grubbs’ test (http://graphpad.com/
quickcalcs/Grubbs1.cfm) and excluded from confidence interval
(CI) calculation. CI was calculated manually using standard error
and the ‘‘tdist’’ function in Microsoft Excel.
Nucleotide Sequence Deposition
The cps locus sequence of isolate 7236-07 has been deposited at
GenBank (accession number KJ363164).
Results
Some Invasive Pneumococcal Isolates are Nontypeable
During the period of 2006–2009, the CDC received 14,328
independent IPD isolates. A subset of these isolates (N= 88,
0.61%) was nontypeable by Quellung and subsequently serotyped
by PCR. Seventy-nine isolates (89.8% of NT) were PCR-
serotypeable or cpsA-positive and thus classified as Group I NT;
their assigned serotypes, prevalence, and the prevalence of
corresponding Quellung-typeable isolates are presented in
Table 1. The remainder (10.2%) were Group II nontypeables.
Group II NT organisms were thus extremely rare causes of IPD
over this period, accounting for only 0.056% of IPD cases.
Group II Nontypeable Organisms Are Generally Null
Capsule Clade 2
The Group II isolates were assayed by PCR for the presence of
NCC-associated genes (i.e., pspK, aliC, and aliD) [14]. No isolates
exhibiting pspK (NCC1) or aliD only (NCC3) were identified;
however, six isolates contained both aliC and aliD and were
classified as NCC2 (Table 1). The cps locus arrangements of
NCC1, NCC2, and NCC3 have been described in detail by others
[10,12,14]. Chromosomal DNA from the remaining three isolates
was subjected to PCR using primers spanning dexB and aliA
[10,14].Two of these isolates repeatedly failed to produce a
product; however, isolate 7236-07 demonstrated a product ,5 kb
in length. We sequenced isolate 7236-07 through this region and
determined that it contained only transposon-related elements
between dexB and aliA (Fig. 1, sequence submitted to GenBank,
accession no. KJ363164) and was 99% identical to the transposon
elements downstream of the serotype 5 cps locus over their shared
sequence (accession no. CR931637, [2]). This is the third IPD
isolate to be described with only transposable elements in its cps
locus [12], and we propose that NCC4 be defined as Group II NT
isolates lacking non-transposon open reading frames [10,14,15].
Group II Nontypeables Obtained in Surveillance Are
Related to Established Nontypeable Lineages
Because these Group II NT isolates were obtained from patients
with IPD rather than nasopharyngeal carriage, we used MLST to
assess their relatedness to previously described nontypeable
lineages (Table 2). Four of these strains revealed MLST genotypes
identical (ST344, ST448, and ST1186) or similar (ST1540,
sharing 5 of 7 alleles with ST344) to those associated with
Invasive Nontypeable Pneumococci
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previously-reported conjunctivitis outbreaks [24,25]. ST1540 was
previously recorded from a nontypeable carriage isolate according
to the MLST database (http://www.mlst.net). Isolate 7236-07 is
the first NCC4 strain to our knowledge in which sufficient residual
elements remain to facilitate the identification of the likely
ancestral serotype, in this case, serotype 5; consistent with this
observation, the sequence type of this strain, ST4840, was
associated with two serotype 5 isolates (www.mlst.net).
Of the two isolates failing to produce a PCR product in the
dexB/aliA region, one belonged to ST191, which has been rarely
Table 1. PCR-serotype Distribution of Nontypeable Pneumococci, 2006–2009.
PCR serotype or serogroup
Quellung NTs Count % total
Quellung-NT (N=88)
Corresponding Quellung Serotype(s) Serotype (count);% total
surveillance isolates (N=14,328)
Group I NT
8 22; 25.0 8 (311); 2.17
19A 8; 9.09 19A (2643); 18.4
7F/7A 7; 7.95 7F (2006), 7A (1); 14.0
9N/9L 6; 6.82 9N (339); 2.37
22F/22A 4; 4.55 22F (1000), 22A (1); 6.99
11A/11D 3; 3.41 11A (364); 2.54
16F 3; 3.41 16F (405); 2.83
3 2; 2.27 3 (1139); 7.95
15B/15C 2; 2.27 15B (145),15C (145); 2.02
19F 2; 2.27 19F (148); 1.03
23B 2; 2.27 23B (214); 1.49
33F/33A/37 2; 2.27 33F (477), 37(13), 33A (2); 3.43
34 2; 2.27 34 (67); 0.47
4 1; 1.14 4 (292); 2.04
6A 1; 1.14 6A (224); 1.56
6C/6D 1; 1.14 6C/6D (651); 4.54
10A 1; 1.14 10A (206); 1.44
15A/15F 1; 1.14 15A (408), 5F (2); 2.86
17F 1; 1.14 17F (179); 1.25
18C/18B/18A/18F 1; 1.14 18C (67), 18B (6), 18A (4), 18F (3); 0.56
23F 1; 1.14 23F (71); 0.50
24F/24A/24B 1; 1.14 24F (3), 24A (1); 0.03
31 1; 1.14 31 (242); 1.69
35F 1; 1.14 35F (133); 0.93
cpsA+ but not serotypeable by PCR 3; 3.41 – (–)
Group II NT
NCC2 (aliC+ aliD+) 6; 6.82
NCC4 (no ORFs) 1; 1.14
Undetermined 2; 2.27
doi:10.1371/journal.pone.0097825.t001
Figure 1. The isolate 7236-07 cps locus does not contain capsular biosynthetic or novel surface protein genes. Schematic of the cps
locus between primers 5419 and 3419 from isolate 7236-07 (deposited to GenBank, accession no. KJ363164). Genes and spacing are to scale. dexB
and aliA are truncated at their 59 and 39 ends, respectively, in the sequence coverage. Annotations of tnp pseudogenes were assigned corresponding
to the serotype 5 cps locus (GenBank no. CR931637).
doi:10.1371/journal.pone.0097825.g001
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reported in association with NT organisms but is strongly
associated with serotype 7F; the remaining isolate belonged to
ST1390, which is associated with serotypes 6A and 6C (Table 2).
Because these two isolates were cpsA-negative and share STs
associated with serotypes detectable in our PCR assays, it is likely
that these strains exhibit gross defects around their respective cps
loci.
PCR-8 Nontypeables Are Overrepresented in Group I
Nontypeables and Contain Inactivating Mutations in
wchA
The serotypes identified by multiplex PCR are listed in Table 1.
When compared to the prevalence of encapsulated serotype 8
isolates, PCR-8 NTs were significantly overrepresented among
NT isolates (P,,0.001). Five additional NT isolates obtained in
mixed culture with Quellung- serotype 8 isolates were determined
to be PCR-8 and were also examined (Table 3). Identical
antibiotic susceptibilities were obtained for these isolates and their
Quellung counterparts, suggesting that the NTs were derived from
the encapsulated isolates (data not shown).
To investigate whether PCR-8 NTs express minor amounts of
capsule, we looked for molecular defects within their cps loci.
Because loss of CPS production in pneumococci frequently results
from mutations in wchA [26–29], we amplified and sequenced
wchA in these isolates (the serotype 8 cps locus is presented in
Figure 2A). When compared to two serotype 8 cps locus reference
sequences [2,30], twenty-three of the twenty-seven PCR-8 strains
contained single base pair changes in wchA, summarized in Table 3
and whose effects are shown in a molecular model of WchA
(Figure 2B). Eleven mutations resulted in premature termination
codons or frameshifts predicted to truncate WchA before amino
acid 335 (Figure 2B). Twelve missense mutations were identified
and were confined to the predicted C-terminal loop encoding the
catalytic portion of the enzyme (Figure 2B, [31]). Isolate 8199-06
contained a short tandem duplication event, and sequencing
revealed a 388-bp deletion internal to wchA of isolate 7631-07
(Table 3). The wchA mutations were likely primary, as we
sequenced the entire cps locus from two isolates and found no
other genetic defects than the wchA mutation. This conclusion is
also supported by the findings of Melchiorre, et al., who identified
mutations in wchA in two serotype 7F IPD NTs and restored CPS
in those strains through overexpression of wild-type wchA [27].
Because isolate 6265-07 reproducibly failed to produce a wchA
product, primers outside this region were used to localize the
defect, and sequencing revealed a large deletion in the cps locus
spanning ,80% of wze and all of wchA, wciQ, and wciR (Table 3,
Figure 2A). The final isolate, 4179-08, exhibited no mutation in
wchA despite producing no CPS as detectable by a flow cytometric
serotyping assay (not shown), and its entire cps locus was
sequenced. We identified five single base pair changes resulting
in alterations to the putative cps gene promoter, wzd (a.k.a. cap8C,
cps8C), and wze (a.k.a. cap8D, cps8D)(Table 3, Figure 2A).
Conclusions/Discussion
Although large numbers of carriage NTs have been studied,
only a limited number of IPD NTs have been studied [10–12,27].
Our study shows that they are isolated from patients with IPD in
less than 1% of cases. Only a small fraction of IPD NTs (7 of 88)
were Group II NTs (i.e., conclusively lacked cps loci) [14]. Most
such isolates (6 of 7) had aliB homologs in place of the cps locus, a
frequently-described finding in Group II NTs of nasopharyngeal
origin [10,12,14]. The extremely low prevalence of these strains is
not surprising when considering that the acquisition of these novel
cps locus-replacing genes almost certainly arose as a fitness
advantage during colonization, as invasive illness is considered a
dead-end path for the organism. Indeed, the recently-identified
PspK protein has been shown to increase adherence during
colonization [12,14,15]. AliB homologs do not appear to influence
adherence to epithelial cells but likely provide advantages in other
facets of colonization [10]. Because their prevalence in IPD is so
rare, NCC isolates may have been obtained from patients who
were already immunocompromised or otherwise susceptible to
infection.
Consistent with previous studies, we found that the vast majority
of these isolates are Group I NTs, retaining at least portions of
their cps loci [11], but a striking observation is that Group I NTs
tend to have serotype 8 cps loci. The observed frequency of PCR-8
among NTs vastly exceeds serotype 8 prevalence in IPD. The
appearance of acapsular serotype 8 strains under continuous
culture conditions using sorbarods has been described; these
isolates lost CPS expression due to introduction of a tandem
Table 2. Multi-locus sequence types of Group II Nontypeable Isolates, 2006–2009.
Isolate ST1 Related Serotype(s) Comments
NCC2 (aliC+ aliD+)
2008236031 448 NT Associated with conjunctivitis
4670-07 1054 NT Two-locus variant of ST344
9034-06 344 NT Associated with conjunctivitis
8542-07 1186 NT Associated with conjunctivitis
2010216117 1540 NT, 15 Double locus variant of ST4589 (associated with NT and 9V)
2010201915 1540 NT, 15 (see above)
NCC4 (no known ORFs)
7236-07 4840 5 Serotype 5 lineage
Not Determined
8296-06 1390 6A and 6C
2008230408 191 7F and NT NTs represent 7 of 274 reported ST191 isolates
1Data obtained from MLST.net, accessed January 26, 2014.
doi:10.1371/journal.pone.0097825.t002
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duplication within wchA [28]. However, we did not find a fixed
pattern in wchA mutations, nor did we find any characteristic in
serotype 8 wchA that should predispose it to mutation. In fact, of
the other PCR serogroups/-types identified in this study with wchA
genes homologous to that of serotype 8 (serotypes 6, 8, 11A, 15A,
17F, 19A, 23F, 23B, 33F, and 34) [2,32], sharing between 93.0%
and 96.5% nucleotide identity (analysis of sequences in references
2 and 30) only serotype 8 was overrepresented among IPD NTs.
Only three isolates retain the potential to revert (two potential slip
strand mutations and one tandem repeat [28]); however, with at
longest a nine bp insertion, the expected frequency of reversion
would be at most ,1025 [28,33]. The even distribution between
frameshift and point mutations in wchA, in addition to the
observation of similar mutations found during generation of
otherwise-lethal mutations in the cps locus [26,29], suggests that
these NTs are producing very little to no CPS rather than a down-
regulated amount of capsule as has been hypothesized [11]. All
mutations in wchA are predicted to perturb or eliminate the C-
terminal catalytic domain of WchA [31]. We thus conclude that
the majority of IPD NTs are defective in CPS production,
frequently due to point mutations in wchA that would not be
identified in superficial genetic analyses such as PCR or
microarray.
The inactivation of CPS expression in invasive Group I NTs is
unexpected because of the protective role CPS plays for
pneumococci. These isolates may thus represent an in vitro
artifact and arise through an unknown mechanism during isolation
and subculture in the laboratory. Although in certain serotypes
(e.g., serotype 3, which exhibits mucoid colonies) nonencapsulated
strains are easily distinguished from encapsulated strains on BAP,
in other serotypes, the difference between a small colony and a
nonencapsulated colony is not always apparent. Because it is
common practice to select only one colony from a culture for
Quellung analysis, the chance of inadvertently selecting a CPS-
Table 3. Mutations in PCR-serotype 8 Isolates.
Isolate Mutation(s)a,b Resultc
Isolates obtained as nontypeable in pure culture
4179-08 T2158G, T5050A, G5230A, G5252A, C5540T Putative promoter 210 region mutation, Wzd (D226E), Wze (T51T, A59T, P155S)
6265-07 DA5217-A8124 Wze (E57FSd), DwchA-wciR
2010200824 G5869T WchA (E30*d)
7518-07 G5875T WchA (E32*)
8286-06 DC5900 WchA (A40FS)
8199-06 Tandem repeat of 5960-5968 WchA (Y63*)
8390-06 Insert C before C6003 WchA (L75FS)
2008008783 C6084A WchA (Y101*)
7631-07 DA6232-G6619 WchA (I151FS)
9164-06 G6508T WchA (G243*)
8083-06 C6682T WchA (R301C)
2008232774 C6717G WchA (Y312*)
8158-06 A6718G WchA (K313E)e
8402-06 A6718G WchA (K313E)e
2008008362 C6724G WchA (R315G)
7445-07 DA6751 WchA (R326FS)
2009211113 C6784T WchA (Q335*)
2008008580 G6833A WchA (G351D)
8174-06 C6844G WchA (R355G)
7145-06 A6872T WchA (Q364L)
6841-06 C6920T WchA (P380L)
2008227824 C6923T WchA (P381L)
Nontypeable isolates obtained in mixed culture with a Quellung-positive isolate
8992-06 DC6194 WchA (A38FS)
5238-07 DA6690 WchA (K304FS)
5241-07 C6861A WchA (D360E)
2009208249 C6923G WchA (P381R)
2009212775 G7090A WchA (D437N)
aSequence numbers correspond to GenBank accession No. AJ239004.
bPolymorphisms present in an alternative serotype 8 sequence (accession No. CR931644) were ignored.
cResidue numbers correspond to amino acid sequence deduced from cap8C (Wzd), cap8D (Wze), or cap8E (WchA) in GenBank accession No. AJ239004.
dFS, frameshift;
*, stop.
eResidue previously identified as a site of inactivating mutation [29].
doi:10.1371/journal.pone.0097825.t003
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negative colony would increase the closer in size it is to the CPS-
positive colony, leading to a selection bias. For serotype 3, one
would expect a bias in the opposite direction, and this was what
was observed: the ratio of PCR-3 isolates to Quellung-serotype 3
(0.0018) was the lowest when compared to this metric for other
serotypes with at least 2 NT isolates (mean =0.0091; 95% CI
0.0040–0.0142). However, serotypes 34 and 9N/9L were above
the CI, and their individual chi-squared values when compared to
their expected prevalences (7.14 and 9.17, respectively) were
unremarkable as compared to that of serotype 8 (240.05, ratio
= 0.071), so this does not appear to completely explain the
abundance of PCR-8 isolates.
Alternatively, one could envision a population of acapsular
organisms arising during infection as the host response begins to
target CPS. Under such circumstances, encapsulated organisms
would be targeted by antibodies or innate lectins and rapidly
opsonized with C3b through the classical or lectin pathways,
depleting complement levels in a local environment to sufficiently
permit transient survival of nonencapsulated organisms, which
would still possess pneumococcal anti-complement enzymes
(reviewed in reference [34]). This could account for the
observation that NT isolates of certain serotypes are sometimes
obtained in mixed culture with encapsulated isolates (LK Sher-
wood and B Beall, unpublished observations). Less extreme
microevolutions, involving intra-serogroup changes, are known
to take place. For example, in serogroups 9 and 11, one member of
the serogroup (9A/11E) appears to arise independently from a
different member of the serogroup (9V/11A); in both cases, the
serotype switch occurs through inactivation of a single gene in the
cps locus encoding an acetyl transferase, resulting in absence of an
acetylated residue on the CPS repeat unit [35,36]. Because each
isolate of 9A/11E contained a different inactivating mutation, the
Figure 2. PCR-8 nontypeable isolates contain inactivating mutations in wchA. A. Schematic of the serotype 8 cps locus (GenBank accession
No. AJ239004). Alternative nomenclature is shown for regulatory genes. B. Molecular model of WchA as predicted by TMPRED (http://www.ch.
embnet.org/software/TMPRED_form.html). Black arrows indicate nonsense (*) and frameshift (**) mutations; gray arrows indicate missense mutations.
Residue numbers correspond to the predicted primary amino acid sequence for WchA.
doi:10.1371/journal.pone.0097825.g002
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authors concluded that these serotypes have arisen repeatedly over
time during infection from strains producing the acetylated version
of the CPS [35–37]. The low prevalence of IPD NTs could suggest
underlying defects in the host patient’s immunity, permitting
survival of an unencapsulated population during infection.
In contrast to carriage, where Group II NTs are frequently
isolated [10,12,14], IPD NTs are composed primarily of Group I
NTs with defective cps loci rather than merely reduced CPS
expression. Regardless of how Group I IPD NTs arise, this finding
reaffirms the essential nature of CPS in at minimum the
establishment of IPD and suggests that the rare Group II IPD
NT infection is likely to occur in an individual predisposed to such
infections due to underlying immune defect. This finding, taken
with recent work showing microevolution of CPS serotypes—likely
occurring within the host during IPD [35–37]—suggests that
caution is necessary when inferring characteristics of invasive
isolates based on those determined of carriage strains.
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